COVID-19

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Immunosuppression and COVID-19 Boosters

sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19

Dapagliflozin for Long COVID Syndrome

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

Safety and Immunogenicity of NVX-CoV2705

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival

Study of VYD2311 for the Prevention of COVID-19

Outpatient Treatment With Anti-Coronavirus Immunoglobulin

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome

COVID-19 Booster Study in Healthy Adults in Australia

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

RECLAIM Adaptive Platform Trial for PCC Treatments

Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

Taurine Supplementation in Long COVID

PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial

Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 Vaccines

A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings

Investigating Measurable PRO Acuity Trial (IMPACT) is a Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin to Improve Neurocognitive and Physical Function of Subjects With Long COVID-19/Post-Acute Sequelae of COVID-19 (PASC).

A Study of Apabetalone in Subjects With Long -COVID

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)

Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children

A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia

Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

RCT of Efficacy and Safety of CP003 on CFS/ME or Post-COVID Fatigue

Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers

HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

Pycnogenol® in Post-COVID-19 Condition

Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine

A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination

Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial

Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms

A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years

Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial

Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19

The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Novel Regimens in COVID-19 Treatment

Convalescent Plasma Collection and Treatment in Pediatrics and Adults

ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection

Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.

Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine

Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS

A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

The COVID-RASi Trial (COVID-19)

A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19

Evaluating Emetine for Viral Outbreaks (EVOLVE)

Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity

Study of LAU-7b for the Treatment of Long COVID in Adults

Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure

Fluvoxamine for Long COVID-19

A Study of Baricitinib (LY3009104) in Children With COVID-19

Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age

A Study of S-268019 for the Prevention of COVID-19

ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19

Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)

ACTIV-6: COVID-19 Study of Repurposed Medications

Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)

Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults

To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.

The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01)

Nebulised Heparin in Patients With Severe COVID-19

ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.

A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals

The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19

Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection

Sarilumab COVID-19

Vitamin D for COVID-19 Trial

Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)

Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older

Booster Study of SpikoGen COVID-19 Vaccine

A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19

A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19

COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada

Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19

TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)

Investigating a Vaccine Against COVID-19

Clinical Study of Tanshinone Capsules Against COVID-19

Effects of Immulina TM Supplements With PASC Patients

Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia

Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors

Trial of Imatinib for Hospitalized Adults With COVID-19

A Strain Change Study for SARS-CoV-2 rS Vaccines

Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial

Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines

EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19

A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age

A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa

Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Inhaled Heparin for Hospitalised COVID-19 Patients

A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19

Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults

A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults

Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients

Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19

International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response

Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19

A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

Frontline Clinician Psilocybin Study

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine

Lot Consistency Study of COVID-19 and Influenza Combination Vaccine

Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms

Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2

Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection

Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine

Aggrenox To Treat Acute Covid-19

Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19

COVID-19 Vaccine Boosters in Patients With CKD

Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)

Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients

Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine

A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants

A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults

Study of Obeldesivir in Children and Adolescents With COVID-19

REVERSE-Long COVID-19 With Baricitinib Study

Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care

Vitamin D and COVID-19 Management

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Novel Experimental COVID-19 Therapies Affecting Host Response

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)

A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older

#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19

Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients

Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts)

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial

Study of Obeldesivir in Nonhospitalized Participants With COVID-19

Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness

Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).

Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older

Effect of Traditional Chinese Medicine of Severe COVID-19

Anti-inflammatory Drug Algorithm for COVID-19 Home Treatment

Cromolyn Sodium for Treatment of COVID-19 Pneumonia

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19

A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)

Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19

A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

Immunogenicity and Safety Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine(GBP510) Adjuvanted with AS03 in Adults Aged 18 Years and Older

Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)

Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia.

Dietary Supplements for COVID-19

Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, with CoViD-19

Trial of Treatments for COVID-19 in Hospitalized Adults

Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults

BCG Vaccination to Protect Healthcare Workers Against COVID-19

Pirfenidone LP or Collagen-polyvinylpyrrolidone in COVID-19

Essential Amino Acid Supplementation in Older Adult COVID-19 Patients

Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19

Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults

Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

Evaluation of ADG20 for the Prevention of COVID-19

SARS-CoV-2 and Acetylsalicylic Acid (SARA)

A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19

Endothelial Protection in Post COVID-19 Patients With Sulodexide

ACTIV-2: A Study for Outpatients With COVID-19

Contrast Enhanced Ultrasound in COVID-19

A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose.

A Phase II/III Study of Sargramostim

Repurposing of Chlorpromazine in Covid-19 Treatment

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19

Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal

A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIAL

Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

COVID-19 3rd Dose Vaccine in Transplant Patients

Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above

A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.

Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia

To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19

Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19

Clinical Trial For SARS-CoV-2 Vaccine (COVID-19)

A Phase III Confirmatory Study of K-237

COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)

Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)

Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen

A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older

Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection

Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines

Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19

Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Moderate COVID19.

A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness

Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)

A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19)

The Prevent Severe COVID-19 (PRESECO) Study

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION

Antiviral Agents Against COVID-19 Infection

Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)

A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19

COVID-19 Fourth Dose Study in Australia

Losmapimod Safety and Efficacy in COVID-19

Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19.

Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19

Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine

Phase 3 Booster Vaccination Against COVID-19

Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov)

Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19)

Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso

Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals

COVID-19 Algorithm Treatment at Home

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Study of Remdesivir in Participants Below 18 Years Old With COVID-19

Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.

Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression

PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)

Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial

Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19

A Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19

Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Mild COVID-19

LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Efficacy of TCM Capsules Lian Hua Qing Wen Jiao Nang in Mild COVID-19 Patients

ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure

A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children

A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects

Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine

Furosemide as Supportive Therapy for COVID-19 Respiratory Failure

Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine

Homeopathic Treatment of Post-acute COVID-19 Syndrome

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults

An Open-Label Study of Apabetalone in Covid Infection

PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS

Non-inferiority Trial on Treatments in Early COVID-19

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)

A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above

A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222

Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents

Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients

Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years

Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection

Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2

A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection

A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19

Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)

Immune Modulators for Treating COVID-19

JT001 (VV116) for the Early Treatment of COVID-19

Study to Assess the Effect of Meplazumab on COVID-19

Study on the Safety and Efficacy of Meplazumab for Injection Patients COVID-19

the Safety and Efficacy of Meplazumab in Patients With COVID-19

IH Convidecia as Second Booster Dose Against Breakthrough Infections

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

Safety and Immunogenicity of VLA2001 Adults Aged ≥56 Years

Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease

ACTIV-3: Therapeutics for Inpatients With COVID-19

Combined Antihistaminics Therapy in COVID 19 Patients

Immunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in Adults

COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;

Early Treatment of Cytokine Storm Syndrome in Covid-19

Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults

STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19

THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME: A RANDOMIZED CLINICAL TRIAL

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients

A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects

Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50

Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).

Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine

A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine

mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms

Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19

A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19

A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19

Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19

Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure

Randomized Open Investigation Determining Steroid Dose

Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults

A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection

Bucillamine in Treatment of Patients With COVID-19

Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults

Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial

A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19

Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

JT001 (VV116) for the Treatment of COVID-19

A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)

Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)

Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above

A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine

A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection

Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III

Phase 3 Study to Evaluate the Lot Consistency of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine

Ivermectin Treatment Efficacy in Covid-19 High Risk Patients

Efficacy Evaluation of Shen Cao Gan Jiang Tang on Mild and Moderate COVID-19 Patients

Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19

Hamburg Edoxaban for Anticoagulation in COVID-19 Study

Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

Role of Vit-D Supplementation on BioNTech, Pfizer Vaccine Side Effect and Immunoglobulin G Response

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19

Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru

Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic

Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study

Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19

Lessening Organ Dysfunction With VITamin C - COVID-19

Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine

Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population

Efficacy and Safety of Ambervin® and Standard Therapy in Hospitalized Patients With COVID-19

Study of GRAd-COV2 for the Prevention of COVID-19 in Adults

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age

Safety and Immunogenicity of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adults With Chronic Immune-Mediated Diseases

Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I

Proactive Care of Ambulatory COVID19 Patients

COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222

COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases

A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.

Treatment of COVID-19 Patients With Anti-interleukin Drugs

Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia

Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial

Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19)

Efficacy, Safety, and Immunogenicity of Vaccine Reimmunization With a Third Homologous Versus Heterologous Dose Against COVID-19 in Patients Undergoing Solid Organ Transplantation.

Azithromycin for COVID-19 Treatment in Outpatients Nationwide

Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals

Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease

Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients

Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19

Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center

A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis

Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19)

A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients

Safety and Immunogenicity of Inactivated Heterologous Booster Vaccination

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)

Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2

Efficacy and Safety of JT001 (VV116) Compared With Favipiravir

Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above

EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19

Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19

Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults

Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19

Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19

Immunogenicity of Heterologous Versus Homologous Prime Boost Schedule With mRNA and Inactivated COVID-19 Vaccines

Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia

EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19

A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2

A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2

Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19

Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients.

A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients

Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation

Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis

COVID-19 Paediatric VLA2001-321 Study

VIR-7831 for the Early Treatment of COVID-19 in Outpatients

Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults

Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection

Clinical Trial of Favipiravir Treatment of Patients With COVID-19

Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19

Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)

Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients

Open Multicenter Study for Assessment of Efficacy and Safety of Molnupiravir in Adult Patients With COVID-19

Ivermectin for Post Exposure Prophylaxis of Covid-19

Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years

Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine

Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)

Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose

The Role of Resistant Starch in COVID-19 Infection

The DAWN Antivirals Trial for Ambulatory COVID-19 Patients

Efficacy of Amantadine Treatment in COVID-19 Patients

A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults

VA CoronavirUs Research and Efficacy Studies-1

Efficacy and Safety of JT001 (VV116) Compared With Paxlovid

A Phase III, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TD0069 Capsule for Patients With Mild to Moderate COVID-19

CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients

Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India

CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19

suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19

Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure

A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)

Anakinra in the Management of COVID-19 Infection

Catalysing the Containment of COVID-19

Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)

Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)

Treatment for COVID-19 in High-Risk Adult Outpatients

Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia

PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19

A Study of Baricitinib (LY3009104) in Participants With COVID-19

Survival TRial Using CytoKines in COVID-19 (STRUCK Trial)

A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19

Non-inferiority Trial on Monoclonal Antibodies in COVID-19

To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental Oxygen

A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection

Intranasal Insulin for COVID-19-related Smell Loss

Mineralocorticoid Use in COVID-19 Patients

Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19

Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients

BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

Adaptive COVID-19 Treatment Trial 4 (ACTT-4)

The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19

Will Hydroxychloroquine Impede or Prevent COVID-19

Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo

Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients

The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection

Dapagliflozin in Respiratory Failure in Patients With COVID-19

Inhaled Ciclesonide for Outpatients With COVID19

Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)

Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine

A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19

Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19

Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19

Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients

Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)

COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities

Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2)

IntraDermal Versus Intramuscular Comirnaty® Efficacy Study

Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease

Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia

Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients

Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients

MSCs in COVID-19 ARDS

DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19)

Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity

Corticosteroids for COVID-19

Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.

Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19

Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections

Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)

Lessening Organ Dysfunction With VITamin C

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine

Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study)

Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study)

Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19

COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19

Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans

Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection

INB03 for the Treatment of Pulmonary Complications From COVID-19

Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19

Adaptive COVID-19 Treatment Trial 3 (ACTT-3)

Adaptive COVID-19 Treatment Trial 2 (ACTT-2)

Adaptive COVID-19 Treatment Trial (ACTT)

Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.

Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85

Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.

Efficacy of the Infusion of Donor Plasma in COVID-19 Infection

Proxalutamide Treatment for COVID-19 Female Outpatients

Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit

Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)

An Open-label, Randomized, Parallel-arm Study Investigating the Efficacy and Safety of Intravenous Administration of Pamrevlumab Versus Standard of Care in Patients With COVID-19

Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19

Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia

Impact of Colchicine in Hospitalized Colombian Patients With COVID-19

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT

CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients

Convalescent Plasma for Treatment of COVID-19

A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff

Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation

Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)

Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)

BCG Vaccination for Healthcare Workers in COVID-19 Pandemic

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease

Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

Measurement of Viral Load Reduction in the Oral Cavity After a Regimental Use of OC Toothpaste Products

Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum

Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19

Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19

Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)

Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma

Trial of Hydroxychloroquine In Covid-19 Kinetics

A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus

Efficacy of Adaptogens in Patients With Long COVID-19

Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers

Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)

Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection

Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC)

Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease

Favipiravir in High-risk COVID-19 Patients

A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19

Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.

Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients

The South Proxa-Rescue AndroCoV Trial Against COVID-19

OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 "

A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19

Early Intervention in COVID-19: Favipiravir Verses Standard Care

Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19

Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

A Study to Test Whether BI 767551 Can Prevent COVID-19 in People Who Have Been Exposed to SARS-CoV-2

Favipiravir Therapy in Adults With Mild COVID-19

Glutamine Supplementation and Short-term Mortality in Covid-19

Efficacy of Faviprevir in COVID-19 Treatment

Hydroxychloroquine to Prevent SARS-CoV-2 Infection/COVID-19

Role of Famotidine in the Clinical Improvement of COVID-19 Patients.

A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic

Convalescent Plasma in Outpatients With COVID-19

Efficacy of Convalescent Plasma Therapy in Patients With COVID-19

Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine

Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease

Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm

Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic

Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19

AZD1222 Vaccine for the Prevention of COVID-19

Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19

Lipid Emulsion Infusion and COVID-19 Patients

Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers

Xylocaine to Freeze During Unpleasant Nasopharyngeal Swabs

Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19

Hydrocortisone for COVID-19 and Severe Hypoxia

PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial

Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel

Preventing COVID-19 Complications With Low- and High-dose Anticoagulation

The Containing Coronavirus Disease 19 (COVID-19) Trial

Impact of Steroids on Inflammatory Response in Covid-19

Canakinumab in Patients With COVID-19 and Type 2 Diabetes

Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms

Fight COVID-19 Trial

Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above

A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19

Polyvalent Immunoglobulin in COVID-19 Related ARds

Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19

Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment

Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy

Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19

Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia

Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial)

Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia

Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia

Protective Role of Inhaled Steroids for Covid-19 Infection

Ivermectin as a Novel Therapy in COVID-19 Treatment

Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma

Remdesivir Efficacy in Coronavirus Disease

Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment

Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults

Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)

Sevoflurane in COVID-19 ARDS (SevCov)

Ivermectin to Prevent Hospitalizations in COVID-19

Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19

Yinhu Qingwen Granula for the Treatment of Severe CoVID-19

Pre-exposure Prophylaxis for SARS-Coronavirus-2

Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home

Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection

BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST)

Proxalutamide Treatment for Hospitalized COVID-19 Patients

Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients

COVID-19: Salvage TOcilizumab as a Rescue Measure

Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients

Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia

Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS)

Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.

PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams

Outpatient Use of Ivermectin in COVID-19

Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients

Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2

Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19

Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia

The Effect of Vitamin D Supplementation on COVID-19 Recovery

A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2)

Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19

Hydroxychloroquine for COVID-19

COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)

Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?

The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.

OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome

Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure

Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19

Remdesivir Efficacy In Management Of COVID-19 Patients

Efficacy of Psidii Guava's Extract For COVID-19

Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland

ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic

Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19

Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial

BCG Vaccination to Prevent COVID-19

Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt

Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19

Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease

Safety and Efficacy of Ruxolitinib for COVID-19

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion

Safety and Efficacy of Baricitinib for COVID-19

COVID-19 Convalescent Plasma Therapy

Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection

A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger

Convalescent Plasma for Severe COVID-19 Patients

EAT-DUTA AndroCoV Trial

A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19

Ivermectin for Severe COVID-19 Management

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)

Test and Treat COVID 65plus+

Anakinra for COVID-19 Respiratory Symptoms

Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients

Trial to Study the Benefit of Colchicine in Patients With COVID-19

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)

Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection

Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients

Measles Vaccine in HCW

Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection

Multi-site Adaptive Trials for COVID-19

Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study

Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.

Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Response - Active Support for Hospitalised Covid-19 Patients

Corticosteroid Nasal Spray in COVID-19 Anosmia

The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol

Honey & Nigella Sativa Trial Against COVID-19

Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection

The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial

Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial

Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel

Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease

Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients

A Preventive Treatment for Migrant Workers at High-risk of COVID-19

Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19

Chloroquine for Mild Symptomatic and Asymptomatic COVID-19

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment

Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection

Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19

Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease

The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.

Suloexide in the Treatment of Early Stages of COVID-19

Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals

Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment

Prophylactic Ivermectin in COVID-19 Contacts

Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia

Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers

Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression

Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19

DAS181 for STOP COVID-19

COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III

Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19

ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease

Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention

Efficacy and Safety of Favipiravir in Management of COVID-19

VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure

MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b

Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO

Baricitinib Therapy in COVID-19

A Trial of Remdesivir in Adults With Severe COVID-19

A Trial of Remdesivir in Adults With Mild and Moderate COVID-19

Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19